World Anti-Microbial Resistance Congress

Debiopharm, a Swiss-based biopharmaceutical company, develops, manufactures, and invests in innovative therapies and technologies that respond to high unmet medical needs in oncology and bacterial infections.

Abbott is a global healthcare leader that helps people live more fully at all stages of life.

With more than 25 years of molecular experience, BioFire Diagnostics, LLC (now bioMérieux) sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing.

Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics with our first system and we’ve never looked back.

Innovation is complex. The journey from idea to market is not straightforward and requires a diverse range of know-how, investment, market knowledge and research.

Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome.

The Menarini Group is the leading Italian pharmaceutical company in the world, a guarantee of internationally recognised quality.

Microbion is a clinical-stage pharmaceutical company developing a new class of therapeutic compounds to improve the lives of patients with rare and serious diseases.

MicroGenDX specializes in low-cost, highly accurate qPCR + NGS microbial DNA diagnostics — providing answers where cultures or PCR alone have failed. More than 80,000 medical professionals have used MicroGenDx to run more than 1.

Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superb

We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human mic

VectorB2B provide integrated services in drug discovery and screening, project design and implementation, pre-clinical contract research (efficacy and ADME), contract manufacturing and clinical trials management.